These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells. Alissafi T; Hatzioannou A; Legaki AI; Varveri A; Verginis P J Autoimmun; 2019 Nov; 104():102310. PubMed ID: 31421963 [TBL] [Abstract][Full Text] [Related]
5. The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry. Ruste V; Goldschmidt V; Laparra A; Messayke S; Danlos FX; Romano-Martin P; Champiat S; Voisin AL; Baldini C; Massard C; Laghouati S; Marabelle A; Lambotte O; Michot JM Eur J Cancer; 2021 Nov; 158():217-224. PubMed ID: 34627664 [TBL] [Abstract][Full Text] [Related]
6. Metastatic lymph node targeted CTLA4 blockade: a potent intervention for local and distant metastases with minimal ICI-induced pneumonia. Mishra R; Sukhbaatar A; Mori S; Kodama T J Exp Clin Cancer Res; 2023 Jun; 42(1):132. PubMed ID: 37259163 [TBL] [Abstract][Full Text] [Related]
7. Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis. Kumar P; Saini S; Prabhakar BS Semin Cancer Biol; 2020 Aug; 64():29-35. PubMed ID: 30716481 [TBL] [Abstract][Full Text] [Related]
8. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitors. Dougan M; Blidner AG; Choi J; Cooksley T; Glezerman I; Ginex P; Girotra M; Gupta D; Johnson D; Shannon VR; Suarez-Almazor M; Anderson R; Rapoport BL Support Care Cancer; 2020 Dec; 28(12):6129-6143. PubMed ID: 32856210 [TBL] [Abstract][Full Text] [Related]
9. Pickering emulsions with ethiodized oil and nanoparticles for slow release of intratumoral anti-CTLA4 immune checkpoint antibodies. Tselikas L; de Baere T; Isoardo T; Susini S; Ser-Le Roux K; Polrot M; Adam J; Rouanne M; Zitvogel L; Moine L; Deschamps F; Marabelle A J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32571995 [TBL] [Abstract][Full Text] [Related]